Viatris (VTRS) Exchange Rate Effect (2019 - 2026)

Viatris' (VTRS) quarterly Exchange Rate Effect came in at -$4.2 million in Q1 2026, down 125.0% year-on-year from $16.8 million in Q1 2025, and up 82.28% quarter-over-quarter from -$23.7 million in Q4 2025.

Viatris (VTRS) Exchange Rate Effect (2019 - 2026) Analysis & Trends

Viatris' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$4.2 million for Q1 2026.

  • On a quarterly basis, Exchange Rate Effect fell 125.0% year-over-year to -$4.2 million in Q1 2026; TTM through Mar 2026 was -$3.4 million, a 126.67% decrease from a year earlier, with the FY2025 full-year figure at $17.6 million, up 157.33% from the prior year.
  • Exchange Rate Effect improved to -$4.2 million in Q1 2026 per VTRS's latest filing, from -$23.7 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $23.9 million in Q3 2024 and bottomed at -$37.8 million in Q4 2024.
  • The 5-year median for Exchange Rate Effect is -$4.2 million (2026), against an average of -$3.5 million.
  • Biggest YoY gain for Exchange Rate Effect was 1139.13% in 2024; the steepest drop was 1133.33% in 2024.
  • Year by year, Exchange Rate Effect stood at $15.6 million in 2022, then retreated by 18.59% to $12.7 million in 2023, then plunged by 397.64% to -$37.8 million in 2024, then surged by 37.3% to -$23.7 million in 2025, then jumped by 82.28% to -$4.2 million in 2026.
  • Per Business Quant, the three latest VTRS Exchange Rate Effect figures stand at -$4.2 million (Q1 2026), -$23.7 million (Q4 2025), and $17.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -17.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 17.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.01 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -4.20 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -5.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.20 Mn
Mar 31, 2026 -4.20 Mn
Dec 31, 2025 -23.70 Mn
Dec 31, 2025 -23.70 Mn
Sep 30, 2025 17.80 Mn
Sep 30, 2025 17.80 Mn
Jun 30, 2025 6.70 Mn
Jun 30, 2025 6.70 Mn
Mar 31, 2025 16.80 Mn
Mar 31, 2025 16.80 Mn
Dec 31, 2024 -37.80 Mn
Dec 31, 2024 -37.80 Mn
Sep 30, 2024 23.90 Mn
Sep 30, 2024 23.90 Mn
Jun 30, 2024 -4.40 Mn
Jun 30, 2024 -4.40 Mn
Mar 31, 2024 -12.40 Mn
Mar 31, 2024 -12.40 Mn
Dec 31, 2023 12.70 Mn
Dec 31, 2023 12.70 Mn